Timothy P. Kelly - 03 Sep 2021 Form 4 Insider Report for Homology Medicines, Inc. (QTTB)

Role
Chief Operating Officer
Signature
/s/ Bradford Smith, Attorney-in-Fact for Timothy P. Kelly
Issuer symbol
QTTB
Transactions as of
03 Sep 2021
Net transactions value
-$416
Form type
4
Filing time
08 Sep 2021, 16:10:08 UTC
Previous filing
08 Sep 2021
Next filing
12 Jan 2022
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction FIXX Common Stock Sale $416 -54 -100% $7.70* 0 03 Sep 2021 Direct F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The sale reported in the Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 3, 2020.
F2 Includes 54 shares acquired under Issuer's Employee Stock Purchase Plan on August 31, 2021.

Remarks:

Chief Operating Officer